MarketPulse

EASL Congress 2026

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva to Showcase MASH Drug Data at EASL Congress 2026

Inventiva will present lanifibranor data at EASL Congress 2026, demonstrating MASH improvements independent of weight loss and linked to adiponectin induction.
IVAclinical triallanifibranor
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva to Showcase Lanifibranor Data at EASL Congress 2026

Inventiva will present two abstracts on lanifibranor's MASH treatment effectiveness at EASL Congress 2026 in Barcelona, highlighting cardiometabolic and histological improvements.
IVAPhase 3 clinical trialMASH treatment